0001209191-22-060377.txt : 20221208 0001209191-22-060377.hdr.sgml : 20221208 20221208170918 ACCESSION NUMBER: 0001209191-22-060377 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221207 FILED AS OF DATE: 20221208 DATE AS OF CHANGE: 20221208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zakrzewski Joseph S CENTRAL INDEX KEY: 0001331852 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40499 FILM NUMBER: 221453136 MAIL ADDRESS: STREET 1: 509 WATERVIEW PLACE CITY: NEW HOPE STATE: PA ZIP: 18938 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cyteir Therapeutics, Inc. CENTRAL INDEX KEY: 0001662244 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 455429901 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 128 SPRING STREET STREET 2: BUILDING A, SUITE 510 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 857-285-4140 MAIL ADDRESS: STREET 1: 128 SPRING STREET STREET 2: BUILDING A, SUITE 510 CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-12-07 0 0001662244 Cyteir Therapeutics, Inc. CYT 0001331852 Zakrzewski Joseph S C/O CYTEIR THERAPEUTICS, INC. 128 SPRING ST, BUILDING A, SUITE 510 LEXINGTON MA 02421 1 0 0 0 Common Stock 2022-12-07 4 P 0 21202 1.30 A 154618 D Common Stock 58671 I See Footnote Common Stock 149051 I See Footnote The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $1.28 to $1.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. 27,551 of the shares of common stock held directly and indirectly by the Reporting Person were acquired upon early exercise of an option and are subject to forfeiture until they vest. Shares held by Z Investments, LLC, of which the Reporting Person is the Managing Director. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein. Shares held by Z3 Trust, of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein. /s/ Adam M. Veness, as attorney-in-fact for Joseph Zakrzewski 2022-12-08